CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 141 filers reported holding CLOVIS ONCOLOGY INC in Q3 2014. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $86,000 | -90.2% | 2,498 | -73.8% | 0.00% | -100.0% |
| Q3 2015 | $876,000 | -8.2% | 9,524 | -12.3% | 0.00% | 0.0% |
| Q2 2015 | $954,000 | -93.3% | 10,860 | -94.4% | 0.00% | -92.3% |
| Q1 2015 | $14,306,000 | -37.7% | 192,721 | -53.7% | 0.03% | -35.0% |
| Q4 2014 | $22,966,000 | +47.5% | 416,421 | +21.3% | 0.04% | +42.9% |
| Q3 2014 | $15,568,000 | +233.7% | 343,204 | +177.4% | 0.03% | +250.0% |
| Q2 2014 | $4,665,000 | +92.4% | 123,717 | +167.5% | 0.01% | +100.0% |
| Q1 2014 | $2,425,000 | +5814.6% | 46,250 | +6681.5% | 0.00% | – |
| Q3 2013 | $41,000 | -94.9% | 682 | -94.4% | 0.00% | -100.0% |
| Q2 2013 | $811,000 | – | 12,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |